These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12913688)

  • 1. Prostatic calculi do not influence the level of serum prostate specific antigen in men without clinically detectable prostate cancer or prostatitis.
    Lee SE; Ku JH; Park HK; Jeong CK; Kim SH
    J Urol; 2003 Sep; 170(3):745-8. PubMed ID: 12913688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
    Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
    J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels.
    Nadler RB; Humphrey PA; Smith DS; Catalona WJ; Ratliff TL
    J Urol; 1995 Aug; 154(2 Pt 1):407-13. PubMed ID: 7541857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of prostate volume, age, total prostate specific antigen level and acute inflammation on the percentage of free serum prostate specific antigen levels in men without clinically detectable prostate cancer.
    Ornstein DK; Smith DS; Humphrey PA; Catalona WJ
    J Urol; 1998 Apr; 159(4):1234-7. PubMed ID: 9507843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate gland volume is a strong predictor of biopsy results in men 70 years or older with prostate-specific antigen levels of 2.0-10.0 ng/mL.
    Kobayashi T; Mitsumori K; Kawahara T; Nishizawa K; Ogura K; Ide Y
    Int J Urol; 2005 Nov; 12(11):969-75. PubMed ID: 16351653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.
    Oesterling JE; Jacobsen SJ; Chute CG; Guess HA; Girman CJ; Panser LA; Lieber MM
    JAMA; 1993 Aug; 270(7):860-4. PubMed ID: 7688054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of subclinical prostatic inflammation on serum PSA levels in men with clinically undetectable prostate cancer.
    Kwak C; Ku JH; Kim T; Park DW; Choi KY; Lee E; Lee SE; Lee C
    Urology; 2003 Nov; 62(5):854-9. PubMed ID: 14624908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound detection of prostatic calculi as a parameter to predict the appearance of hematospermia after a prostate biopsy.
    Dell'Atti L
    Int Braz J Urol; 2017; 43(6):1136-1143. PubMed ID: 27819756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of serum prostate-specific antigen levels with the results of the prostate needle biopsy.
    Janbaziroudsari H; Mirzaei A; Maleki N
    Bull Cancer; 2016 Sep; 103(9):730-4. PubMed ID: 27345449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate calculi in cancer and BPH in a cohort of Korean men: Presence of calculi did not correlate with cancer risk.
    Hwang EC; Choi HS; Im CM; Jung SI; Kim SO; Kang TW; Kwon DD; Park KS; Ryu SB
    Asian J Androl; 2010 Mar; 12(2):215-20. PubMed ID: 20037598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The incidence of lesions associated with prostatic biopsy and its effect on the serum concentration of the prostate-specific antigen].
    Morote Robles J; López López M; Encabo Duro G; de Torres Ramírez I
    Actas Urol Esp; 1999 May; 23(5):400-5. PubMed ID: 10427813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostatic involvement in men with febrile urinary tract infection as measured by serum prostate-specific antigen and transrectal ultrasonography.
    Ulleryd P; Zackrisson B; Aus G; Bergdahl S; Hugosson J; Sandberg T
    BJU Int; 1999 Sep; 84(4):470-4. PubMed ID: 10468764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differentiation of prostate cancer from benign prostatic disease by total prostate specific antigen dynamic profiles after transrectal prostate biopsy].
    Shao Q; Song J; Zhou ZJ; Du LD
    Zhonghua Nan Ke Xue; 2008 Jul; 14(7):597-601. PubMed ID: 18686378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of digital examination, cystoscopy, transrectal ultrasonography and needle biopsy on the concentration of prostate-specific antigen.
    Deliveliotis C; Alivizatos G; Stavropoulos NJ; Makrychoritis K; Koutsokalis G; Kiriakakis Z; Kostakopoulos A; Dimopoulos C
    Urol Int; 1994; 53(4):186-90. PubMed ID: 7531895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prospective validation of a nomogram predictive of a positive initial prostate biopsy].
    Ramírez-Backhaus M; Bahilo P; Arlandis S; Santamaría Navarro C; Pontones Moreno JL; Jiménez-Cruz F
    Actas Urol Esp; 2010 Jan; 34(1):35-42. PubMed ID: 20223131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum BPSA outperforms both total PSA and free PSA as a predictor of prostatic enlargement in men without prostate cancer.
    Canto EI; Singh H; Shariat SF; Lamb DJ; Mikolajczyk SD; Linton HJ; Rittenhouse HG; Kadmon D; Miles BJ; Slawin KM
    Urology; 2004 May; 63(5):905-10; discussion 910-1. PubMed ID: 15134977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between serum prostate specific antigen concentration and prostate volume.
    Yu HJ; Chiang GJ; Chiu TY; Lai MK
    J Formos Med Assoc; 1995 Nov; 94(11):666-70. PubMed ID: 8527973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
    Djavan B; Zlotta A; Remzi M; Ghawidel K; Basharkhah A; Schulman CC; Marberger M
    J Urol; 2000 Apr; 163(4):1144-8; discussion 1148-9. PubMed ID: 10737484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specific antigen specificity in early prostate cancer detection in men with normal rectal examination and prostate specific antigen between 4.1 and 10 ng./ml.
    Morote J; Raventós CX; Lorente JA; Lopez-Pacios MA; Encabo G; de Torres I; Andreu J
    J Urol; 1997 Aug; 158(2):502-4. PubMed ID: 9224333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of prostate-specific antigen (PSA) mass ratio in the detection of prostate cancer in men with PSA levels of ≤10 ng/mL.
    Hong SK; Oh JJ; Byun SS; Hwang SI; Choo MS; Lee SE
    BJU Int; 2012 Jul; 110(2 Pt 2):E81-5. PubMed ID: 22093144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.